WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke RENBIO wurde als Wortmarke am 29.04.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1599800 |
| Länder | 
|
| Basismarke |
Nr. 90309237,
10. November 2020
|
| Anmeldedatum | 29. April 2021 |
| Ablaufdatum | 29. April 2031 |
Markeninhaber
30-02 48th Avenue
Long Island City NY 11101
US
Long Island City NY 11101
US
Markenvertreter
Morgan, Lewis & Bockius LLP,
One Federal Street
US
Waren und Dienstleistungen
01
Biological products, namely, DNA circle, DNA primers, linear
DNA and buffers for use in research and development of
pharmaceuticals and for manufacture of pharmaceuticals;
biological products, namely, antibodies, multi-specific
antibodies, antibody fragments, proteins, chimeric proteins,
drug conjugates and enzymes, for use in research and
development of pharmaceuticals and for manufacture of
pharmaceuticals
05
Chemical preparations for gene delivery pharmaceuticals for
treating genetic disorders, and for use as medical and
veterinary diagnostic reagents for therapeutic analysis;
biochemical preparations for medical and veterinary
purposes, namely, biochemical preparations for gene therapy,
for treating genetic disorders, and for use as medical and
veterinary diagnostic reagents for gene therapy analysis;
gene therapy and prophylactic products, namely, gene
delivery pharmaceuticals for the treatment of genetic or
cell based conditions; pharmaceutical preparations
containing nucleic acid sequences that encode monoclonal
antibodies for the treatment of cancer, autoimmune diseases,
rare diseases, infectious diseases, inflammatory diseases,
and blood disorders; pharmaceutical compositions for the
prevention and treatment of cancer, autoimmune diseases,
rare diseases, infectious diseases, inflammatory diseases,
and blood disorders; biological preparations for the
treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders; nucleic acid sequences for medical purposes;
pharmaceutical compositions, namely, a nucleotide sequence
that encodes an antigen, such as a DNA plasmid having an
antigen encoding sequence and like DNA, for the prevention
and treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders; pharmaceutical preparations for human use for the
treatment and prevention of cancer, autoimmune diseases,
rare diseases, infectious diseases, inflammatory diseases,
and blood disorders; pharmaceutical preparations for human
and veterinary use, namely, antibiotics, antifungals and
anti-virals
10
Medical apparatus for the administration of
biopharmaceuticals and vaccines, namely, drug delivery
devices and systems; medical devices, namely, for
electroporation mediated administration of drugs to humans
and animals; delivery systems for administration of
biopharmaceuticals and vaccines for the preventive or
treatment of disease in humans and animals; handheld medical
systems and devices using electroporation for the prevention
or treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders in humans and animals; handheld clinical delivery
systems and devices for the application of electrical fields
in tissue, in particular muscle and skin, in conjunction
with the administration of biopharmaceuticals
42
Medical and scientific research in the field of drug
delivery devices; research and development in the
pharmaceutical and biotechnology fields; research and
development of vaccines and medicines
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 10. November 2022 | 2022/46 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. Oktober 2022 | 2022/40 Gaz | CA | Ablehnung |
| 02. August 2022 | 2022/31 Gaz | BR | Ablehnung |
| 26. Mai 2022 | 2022/22 Gaz | JP | Ablehnung |
| 18. Januar 2022 | 2022/7 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 02. Dezember 2021 | 2021/52 Gaz | CN | Ablehnung |
| 01. Dezember 2021 | 2021/48 Gaz | GB | Ablehnung |
| 23. November 2021 | 2021/47 Gaz | EM | Ablehnung |
| 14. Juli 2021 | 2021/29 Gaz | AU | Ablehnung |
| 13. Juli 2021 | 2021/29 Gaz | IN | Ablehnung |
| 29. April 2021 | 2021/24 Gaz | US | Eintragung |
ID: 141599800